How can I calculate the total ultraviolet dose for a patient who is 170 cm tall and weighs 70 kg, and determine the highest per‑cm² dose that can be used without causing phototoxicity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Calculating Maximum Safe UV Dose Without Phototoxicity

To determine the highest UV dose without causing phototoxicity for your patient (170 cm, 70 kg), you must first measure their individual Minimal Erythema Dose (MED) or Minimum Phototoxic Dose (MPD) before any treatment—body surface area calculations alone cannot predict phototoxicity risk. 1

Why Individual Testing is Mandatory

The overriding factor determining safe UV dosing is the patient's own UV skin sensitivity, not their body dimensions. Here's why standardized calculations fail:

  • MED varies by a factor of 4 between white individuals 1
  • MPD for PUVA varies by at least a factor of 10 between individuals due to differences in psoralen pharmacokinetics 1
  • Skin type assessment (Fitzpatrick scale) is subjective and not a reliable predictor of erythemal response 1, 2

The Correct Approach: Pre-Treatment Testing

Before calculating any dose, perform MED/MPD testing:

  1. For UVB phototherapy: Expose small skin areas to graded UV doses using commercial MED testing units

    • Assess for trace erythema at 24 hours post-exposure 1
  2. For PUVA therapy: Use similar graded exposure technique

    • Assess for erythema at 72 hours post-exposure (delayed onset) 1
  3. Critical requirement: The MED/MPD testing device must be calibrated to the identical UV spectrum as your treatment unit 1

Body Surface Area Considerations (Secondary Factor)

While BSA doesn't determine phototoxicity threshold, it affects dose distribution:

  • For your patient (170 cm, 70 kg): BSA ≈ 1.8 m² using standard formulas 3
  • Patient body size reduces cabin irradiance by 8-15% due to UV absorption 1
  • Correction factors: NB-UVB (0.85-0.96), UVA (0.80-0.87) 1
  • Smaller patients intercept proportionally more radiation in standard cabins 4

Dosing Algorithm After MED/MPD Determination

Once you have the patient's measured MED/MPD:

  1. Starting dose: Typically 50-70% of measured MED for UVB therapy
  2. Maximum safe dose per session: Below the measured MED/MPD threshold
  3. Dose escalation: Gradual increases based on clinical response, never exceeding individualized tolerance

Critical Pitfalls to Avoid

  • Never use phototyping alone to determine starting doses—it combines erythema generation and tanning ability inconsistently 1
  • Never assume BSA calculations predict phototoxicity risk—they only help estimate total radiant energy exposure 3
  • Never skip individual MED/MPD testing to "exclude the possible risk of severe burns" 1
  • Ensure all dosimetry equipment is traceably calibrated annually to national standards 1

Equipment Requirements

  • Use traceably calibrated UV radiometers for all measurements 1
  • Verify radiometer has proper cosine response (f2 error specification) 1
  • Ensure MED testing units use identical spectral output to treatment source 1
  • All irradiance values must be within 10% of measured designated patient irradiance 1

Bottom line: For your 170 cm, 70 kg patient, the "highest power without phototoxicity" is unknowable until you perform individualized MED or MPD testing—there is no safe alternative calculation method based on height and weight alone.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.